Literature DB >> 8891346

Molecular cloning and characterization of human FGF8 alternative messenger RNA forms.

A K Ghosh1, D B Shankar, G M Shackleford, K Wu, A T'Ang, G J Miller, J Zheng, P Roy-Burman.   

Abstract

Three alternatively spliced mRNA isoforms of the human fibroblast growth factor-8 (FGF8) gene, expressed in a prostatic carcinoma cell line, have been isolated as cDNA clones and characterized by DNA sequencing. The clones, designated FGF8a, FGF8b, and FGF8e, differ from each other at the NH2-terminal region of the mature proteins and share extensive nucleotide sequence homology in the protein coding region to the corresponding mouse cDNA isoforms that were previously reported. FGF8a and FGF8b exhibit identical amino acid sequences to those of their murine counterparts. FGF8e displays partial sequence variation from the corresponding mouse clone only in the extra exon sequence found in this isoform in both species. There is extensive sequence diversity between FGF8 (human) and Fgf8 (murine) genes in the 3'-untranslated region of the mRNAs. Northern blot analyses revealed FGF8 mRNA expression only in fetal kidney tissue among the various fetal and adult human tissues tested. The reverse transcription-PCR amplification method, however, detected FGF8 mRNA expression in adult prostate, kidney, and testes (the tissues that were tested) and in all normal and tumor prostatic epithelial cell lines examined; although expression of both FGF8a and FGF8b was seen in kidney and testes, FGF8b appeared to be the predominantly expressed species in the prostatic tissue and cell lines analyzed by reverse transcription-PCR. To address the biological effect of specific isoform expression, NIH3T3 cells were transfected with a eukaryotic expression vector containing cDNA for FGF8a, FGF8b, or FGF8e. Consistent with previous reports on differences in the transforming potential of mouse FGF8 isoforms, human FGF8b was found to induce marked morphological transformation to NIH3T3 cells and strong tumorigenicity of the transfected cells in nude mice. Human FGF8a and FGF8e were moderately transforming in NIH3T3 cells, and the transfected cells were moderately tumorigenic in vivo. These results document the production of three alternatively spliced FGF8 mRNAs in human tissues and the transforming and tumorigenic potential of their protein products. Moreover, these data, combined with the tissue-specific expression of these isoforms, suggest that they may have different biological functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891346

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  14 in total

1.  Evolutionary conservation of alternative splicing in chicken.

Authors:  S Katyal; Z Gao; R-Z Liu; R Godbout
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

Review 2.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

3.  Fibulin-1 Binds to Fibroblast Growth Factor 8 with High Affinity: EFFECTS ON EMBRYO SURVIVAL.

Authors:  Victor M Fresco; Christine B Kern; Moosa Mohammadi; Waleed O Twal
Journal:  J Biol Chem       Date:  2016-07-08       Impact factor: 5.157

4.  Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy.

Authors:  Q Wang; G W Stamp; S Powell; P Abel; M Laniado; C Mahony; E N Lalani; J Waxman
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

5.  Transient expression, purification and characterization of bioactive human fibroblast growth factor 8b in tobacco plants.

Authors:  H H Surya Kumar Potula; Sonal Roy Kathuria; A K Ghosh; T K Maiti; S Dey
Journal:  Transgenic Res       Date:  2007-01-31       Impact factor: 2.788

Review 6.  Numerous isoforms of Fgf8 reflect its multiple roles in the developing brain.

Authors:  N Abimbola Sunmonu; Kairong Li; James Y H Li
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

7.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.

Authors:  R K Jain; N Safabakhsh; A Sckell; Y Chen; P Jiang; L Benjamin; F Yuan; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.

Authors:  Johanna Tuomela; Tove J Grönroos; Maija P Valta; Jouko Sandholm; Aleksi Schrey; Jani Seppänen; Päivi Marjamäki; Sarita Forsback; Ilpo Kinnunen; Olof Solin; Heikki Minn; Pirkko L Härkönen
Journal:  BMC Cancer       Date:  2010-10-30       Impact factor: 4.430

9.  Inhibition of glutathione biosynthesis alters compartmental redox status and the thiol proteome in organogenesis-stage rat conceptuses.

Authors:  Craig Harris; Daniel Z Shuster; Rosaicela Roman Gomez; Karilyn E Sant; Matthew S Reed; Jan Pohl; Jason M Hansen
Journal:  Free Radic Biol Med       Date:  2013-06-02       Impact factor: 7.376

10.  FGF8 isoform b expression in human prostate cancer.

Authors:  V J Gnanapragasam; M C Robinson; C Marsh; C N Robson; F C Hamdy; H Y Leung
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.